Expertise in
3
conditions

Michael B. Sawyer

11560 University Avenue, 
Edmonton, AB, CA 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
3
conditions
11560 University Avenue, 
Edmonton, AB, CA 

Overview

Michael Sawyer practices in Edmonton, Canada. Mr. Sawyer is highly rated in 3 conditions, according to our data. His top areas of expertise are Muscle Atrophy, Hereditary Paraganglioma-Pheochromocytoma Syndrome, Colorectal Cancer, Pancreatic Cancer, and Liver Transplant.

His clinical research consists of co-authoring 105 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

11560 University Avenue, Edmonton, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
An Open-label Phase II Study of Lutetium-177 [DOTA0, Tyr3] Octreotate (Lu-DOTA-TATE) Treatment in Patients With Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: August 08, 2025
Intervention Type: Drug
Study Drug: [177]Lu-DOTA-TATE
Study Phase: Phase 2
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
A Phase I/II Study of Gallium-68 HA-DOTATATE ([68]Ga-HA-DOTATATE) in Patients With Known or Suspected Somatostatin Receptor Positive Tumours
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: [68]Ga-HA-DOTATATE
Study Phase: Phase 1/Phase 2
A Radiopharmacokinetic and Radiodosimetric Phase I/II Imaging Study of 1-alpha-D-(5-[131I]Iodo-5-deoxyarabinofuranosyl)-2-Nitroimidazole (131I-IAZA) in Patients With Locally Advanced or Metastatic Solid Tumors
A Radiopharmacokinetic and Radiodosimetric Phase I/II Imaging Study of 1-alpha-D-(5-[131I]Iodo-5-deoxyarabinofuranosyl)-2-Nitroimidazole (131I-IAZA) in Patients With Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Withdrawn
Publish Date: July 11, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of Ciforadenant as Single Agent and in Combination With Atezolizumab in Patients With Selected Incurable Cancers
A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of Ciforadenant as Single Agent and in Combination With Atezolizumab in Patients With Selected Incurable Cancers
Enrollment Status: Completed
Publish Date: August 30, 2021
Intervention Type: Drug
Study Drugs: Ciforadenant, Ciforadenant+Atezolizumab
Study Phase: Phase 1
View 2 Less Clinical Trial

104 Total Publications

New insights into total and resting energy expenditure using state-of-the-art methods in cancer survivors: a cross-sectional study.
New insights into total and resting energy expenditure using state-of-the-art methods in cancer survivors: a cross-sectional study.
Journal: The American journal of clinical nutrition
Published: July 04, 2025

Frequently Asked Questions about Michael B. Sawyer

Is Michael B. Sawyer a top-rated expert for Muscle Atrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Michael B. Sawyer is classified as an Distinguished expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael B. Sawyer participate in research or clinical trials?

Yes. Michael B. Sawyer has published 104 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Michael B. Sawyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sawyer's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile